Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Aptamer licences Optimer binders for swine vaccines

Aptamer Group plc has secured a significant global licensing deal with the University of Glasgow, advancing synthetic binders for vaccines in swine health...

April 30, 2025

One Health Group accelerates expansion amid soaring demand

One Health Group is transforming healthcare with impressive growth and a commitment to tackling NHS waiting times, solidifying its role as a trusted provider...

April 29, 2025

Advancing RSV research with the New RSV-B London strain

Discover hVIVO's groundbreaking RSV-B London strain, a pivotal advancement in respiratory virus research, enhancing vaccine and antiviral development for RSV...

April 29, 2025

AstraZeneca Plc reports revenue up 10%, strong pipeline progress

AstraZeneca Plc's Q1 2025 results reveal strong growth and a focus on pipeline delivery, setting the stage for ambitious goals leading to 2030...

April 29, 2025

Nuformix updates Registered Office and Company Secretary

Nuformix plc (LON:NFX) has, effective immediately, relocated its registered office to a new London address and appointed Shaun Zulafqar as Company Secretary...

April 29, 2025

Aptamer to present Optimer® liver targeting data at 2025 ASGCT

Aptamer Group plc is set to unveil groundbreaking data on its Optimer® delivery vehicle for fibrotic liver disease at the 2025 ASGCT Annual Meeting...

April 29, 2025

Cizzle Bio expands into Caribbean with first contract, secures early royalties

Cizzle Biotechnology announces significant strides in early lung cancer detection through its partner's first Caribbean contract, boosting its biomarker test rollout...

April 28, 2025

One Health Group delivers 20% revenue surge after AIM debut

One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...

April 25, 2025

Professor Sir Chris Evans on EDX Medical’s new testicular cancer test (AQSE:EDX)

EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...

April 25, 2025

Viral innovation drives health preparedness and market opportunity

As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...

April 24, 2025

Aptamer Group publishes new Corporate Presentation and Investor Factsheet

Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...

April 24, 2025

One Health Group FY25 revenue up 22%, record NHS demand

One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...

April 24, 2025

EDX launches groundbreaking blood test for testicular cancer

Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...

April 23, 2025

How patient behaviour transformed first-in-human dosing

Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...

April 22, 2025

DCC Plc to sell healthcare unit for £1.05 billion

DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...

April 22, 2025

AstraZeneca Plc Enhertu trial hits key PFS goal

The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...

April 22, 2025

HUTCHMED completes Savolitinib trial enrollment

HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...

April 22, 2025

Spine care surge positions One Health for investor growth

Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...

April 17, 2025

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

April 17, 2025

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

April 16, 2025

News and Interview Alerts

Company Presentations

R&Q Insurance Holdings overview, investment case and progress (VIDEO)

TEAM plc poised for future growth (VIDEO)

Pennant International Group Investor Presentation with CEO Philip Walker

Open Orphan Investor Presentation – 2021 a good year, 2022 will be a great year

Q&As

Volta Finance: Insights into volatility, strengths and risk protections (LON:VTA)

11 July 2025

Time Finance’s Ed Rimmer on record results and three-year growth plan (LON:TIME)

7 July 2025

Hardman & Co

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

Green News

Drax Group completes £300m buyback and launches £75m extension tranche

9 October 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

BrokerTalk

NIOX Group a ‘Buy’ with Dependable Growth and Cashflow, Singer (LON: NIOX)

1 July 2025

Global Opportunities Trust Shows Its Mettle | QuotedData

30 June 2025

High-Grade Tungsten Results Spark Optimism for Great Western Mining – Shard Capital

19 June 2025

RM plc Embarks on New Growth Chapter with RM Ava Launch – Singer Capital Markets

17 June 2025

Norcros Builds Momentum in FY25 with Strong UK Performance – Equity Development

17 June 2025

Funds

Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC)

10 October 2025

CMC Markets plc software stack, scale-up potential and cash generation excites Gervais Williams (LON:CMCX)

10 October 2025

Fund manager interview on Diversified Energy – US gas, fantastic yield and growing US base (LON:DEC)

10 October 2025

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

WETHERSPOON (JDW.L) Stock Analysis: Exploring a Potential 18% Upside Despite Current Challenges

10 October 2025

Vistry Group PLC (VTY.L): Investor Outlook Amidst Narrow Potential Upside and Contrasting Analyst Ratings

10 October 2025

Trustpilot Group (TRST.L) Stock Analysis: Exploring a Potential 51% Upside in the Tech Sector

10 October 2025

VinaCapital Vietnam Opportunity Fund (VOF.L) Stock Analysis: Unearthing the Potential Amid Limited Analyst Coverage

10 October 2025

Workspace Group PLC (WKP.L): Investor Outlook on Growth Potential Amid Elevated Dividend Yield

10 October 2025

Health

Aptamer licences Optimer binders for swine vaccines

Aptamer Group plc has secured a significant global licensing deal with the University of Glasgow, advancing synthetic binders for vaccines in swine health...

April 30, 2025

One Health Group accelerates expansion amid soaring demand

One Health Group is transforming healthcare with impressive growth and a commitment to tackling NHS waiting times, solidifying its role as a trusted provider...

April 29, 2025

Advancing RSV research with the New RSV-B London strain

Discover hVIVO's groundbreaking RSV-B London strain, a pivotal advancement in respiratory virus research, enhancing vaccine and antiviral development for RSV...

April 29, 2025

AstraZeneca Plc reports revenue up 10%, strong pipeline progress

AstraZeneca Plc's Q1 2025 results reveal strong growth and a focus on pipeline delivery, setting the stage for ambitious goals leading to 2030...

April 29, 2025

Nuformix updates Registered Office and Company Secretary

Nuformix plc (LON:NFX) has, effective immediately, relocated its registered office to a new London address and appointed Shaun Zulafqar as Company Secretary...

April 29, 2025

Aptamer to present Optimer® liver targeting data at 2025 ASGCT

Aptamer Group plc is set to unveil groundbreaking data on its Optimer® delivery vehicle for fibrotic liver disease at the 2025 ASGCT Annual Meeting...

April 29, 2025

Cizzle Bio expands into Caribbean with first contract, secures early royalties

Cizzle Biotechnology announces significant strides in early lung cancer detection through its partner's first Caribbean contract, boosting its biomarker test rollout...

April 28, 2025

One Health Group delivers 20% revenue surge after AIM debut

One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...

April 25, 2025

Professor Sir Chris Evans on EDX Medical’s new testicular cancer test (AQSE:EDX)

EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...

April 25, 2025

Viral innovation drives health preparedness and market opportunity

As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...

April 24, 2025

Aptamer Group publishes new Corporate Presentation and Investor Factsheet

Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...

April 24, 2025

One Health Group FY25 revenue up 22%, record NHS demand

One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...

April 24, 2025

EDX launches groundbreaking blood test for testicular cancer

Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...

April 23, 2025

How patient behaviour transformed first-in-human dosing

Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...

April 22, 2025

DCC Plc to sell healthcare unit for £1.05 billion

DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...

April 22, 2025

AstraZeneca Plc Enhertu trial hits key PFS goal

The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...

April 22, 2025

HUTCHMED completes Savolitinib trial enrollment

HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...

April 22, 2025

Spine care surge positions One Health for investor growth

Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...

April 17, 2025

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

April 17, 2025

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

April 16, 2025